Alkyl Amines Chemicals Limited (ALKYLAMINE) - Net Assets
Based on the latest financial reports, Alkyl Amines Chemicals Limited (ALKYLAMINE) has net assets worth Rs15.33 Billion INR (≈ $165.83 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs18.95 Billion ≈ $204.98 Million USD) and total liabilities (Rs3.62 Billion ≈ $39.15 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Alkyl Amines Chemicals Limited total assets for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs15.33 Billion |
| % of Total Assets | 80.9% |
| Annual Growth Rate | 19.73% |
| 5-Year Change | 54.92% |
| 10-Year Change | 500.67% |
| Growth Volatility | 11.72 |
Alkyl Amines Chemicals Limited - Net Assets Trend (2006–2026)
This chart illustrates how Alkyl Amines Chemicals Limited's net assets have evolved over time, based on quarterly financial data. Check ALKYLAMINE goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Alkyl Amines Chemicals Limited (2006–2026)
The table below shows the annual net assets of Alkyl Amines Chemicals Limited from 2006 to 2026. For live valuation and market cap data, see Alkyl Amines Chemicals Limited stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | Rs15.33 Billion ≈ $165.83 Million |
+9.33% |
| 2025-03-31 | Rs14.02 Billion ≈ $151.67 Million |
+10.68% |
| 2024-03-31 | Rs12.67 Billion ≈ $137.04 Million |
+8.40% |
| 2023-03-31 | Rs11.69 Billion ≈ $126.42 Million |
+18.10% |
| 2022-03-31 | Rs9.90 Billion ≈ $107.04 Million |
+24.90% |
| 2021-03-31 | Rs7.92 Billion ≈ $85.70 Million |
+47.68% |
| 2020-03-31 | Rs5.37 Billion ≈ $58.03 Million |
+41.55% |
| 2019-03-31 | Rs3.79 Billion ≈ $41.00 Million |
+22.67% |
| 2018-03-31 | Rs3.09 Billion ≈ $33.42 Million |
+21.05% |
| 2017-03-31 | Rs2.55 Billion ≈ $27.61 Million |
+22.09% |
| 2016-03-31 | Rs2.09 Billion ≈ $22.61 Million |
+13.48% |
| 2015-03-31 | Rs1.84 Billion ≈ $19.93 Million |
+22.86% |
| 2014-03-31 | Rs1.50 Billion ≈ $16.22 Million |
+29.03% |
| 2013-03-31 | Rs1.16 Billion ≈ $12.57 Million |
+18.55% |
| 2012-03-31 | Rs980.47 Million ≈ $10.60 Million |
+15.01% |
| 2011-03-31 | Rs852.48 Million ≈ $9.22 Million |
+15.08% |
| 2010-03-31 | Rs740.76 Million ≈ $8.01 Million |
+12.39% |
| 2009-03-31 | Rs659.11 Million ≈ $7.13 Million |
+2.65% |
| 2008-03-31 | Rs642.12 Million ≈ $6.94 Million |
+8.41% |
| 2007-03-31 | Rs592.34 Million ≈ $6.41 Million |
+41.53% |
| 2006-03-31 | Rs418.53 Million ≈ $4.53 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Alkyl Amines Chemicals Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1458368700000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs14.58 Billion | 95.11% |
| Common Stock | Rs102.40 Million | 0.67% |
| Other Components | Rs647.61 Million | 4.22% |
| Total Equity | Rs15.33 Billion | 100.00% |
Alkyl Amines Chemicals Limited Competitors by Market Cap
The table below lists competitors of Alkyl Amines Chemicals Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Mirae Asset Daewoo Co Ltd Pref
KO:00680K
|
$1.01 Billion |
|
FS Credit Opportunities Corp.
NYSE:FSCO
|
$1.01 Billion |
|
Omada Health, Inc. Common Stock
NASDAQ:OMDA
|
$1.01 Billion |
|
Daktronics Inc
NASDAQ:DAKT
|
$1.01 Billion |
|
Aedas Homes SL
MC:AEDAS
|
$1.01 Billion |
|
UP FINT. HLDG (SP.ADR) A
F:1M5
|
$1.01 Billion |
|
EPIC Suisse AG
SW:EPIC
|
$1.01 Billion |
|
Amoy Diagnostics Co Ltd
SHE:300685
|
$1.01 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Alkyl Amines Chemicals Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 14,024,900,000 to 15,333,700,000, a change of 1,308,800,000 (9.3%).
- Net income of 1,800,000,000 contributed positively to equity growth.
- Dividend payments of 511,500,000 reduced retained earnings.
- New share issuances of 5,700,000 increased equity.
- Other comprehensive income decreased equity by 409,441,000.
- Other factors increased equity by 424,041,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs1.80 Billion | +11.74% |
| Dividends Paid | Rs511.50 Million | -3.34% |
| Share Issuances | Rs5.70 Million | +0.04% |
| Other Comprehensive Income | Rs-409.44 Million | -2.67% |
| Other Changes | Rs424.04 Million | +2.77% |
| Total Change | Rs- | 9.33% |
Book Value vs Market Value Analysis
This analysis compares Alkyl Amines Chemicals Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.08x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 193.21x to 6.08x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-03-31 | Rs9.44 | Rs1824.40 | x |
| 2007-03-31 | Rs11.62 | Rs1824.40 | x |
| 2008-03-31 | Rs12.59 | Rs1824.40 | x |
| 2009-03-31 | Rs12.93 | Rs1824.40 | x |
| 2010-03-31 | Rs14.53 | Rs1824.40 | x |
| 2011-03-31 | Rs16.72 | Rs1824.40 | x |
| 2012-03-31 | Rs19.23 | Rs1824.40 | x |
| 2013-03-31 | Rs22.79 | Rs1824.40 | x |
| 2014-03-31 | Rs29.41 | Rs1824.40 | x |
| 2015-03-31 | Rs36.14 | Rs1824.40 | x |
| 2016-03-31 | Rs41.01 | Rs1824.40 | x |
| 2017-03-31 | Rs50.06 | Rs1824.40 | x |
| 2018-03-31 | Rs60.60 | Rs1824.40 | x |
| 2019-03-31 | Rs74.14 | Rs1824.40 | x |
| 2020-03-31 | Rs104.95 | Rs1824.40 | x |
| 2021-03-31 | Rs154.95 | Rs1824.40 | x |
| 2022-03-31 | Rs193.44 | Rs1824.40 | x |
| 2023-03-31 | Rs228.42 | Rs1824.40 | x |
| 2024-03-31 | Rs247.58 | Rs1824.40 | x |
| 2025-03-31 | Rs273.96 | Rs1824.40 | x |
| 2026-03-31 | Rs299.86 | Rs1824.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Alkyl Amines Chemicals Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.74%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.72%
- • Asset Turnover: 0.81x
- • Equity Multiplier: 1.24x
- Recent ROE (11.74%) is below the historical average (19.73%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | 10.28% | 3.84% | 0.70x | 3.82x | Rs1.19 Million |
| 2007 | 13.97% | 6.30% | 0.70x | 3.16x | Rs23.51 Million |
| 2008 | 13.53% | 5.48% | 0.72x | 3.42x | Rs22.66 Million |
| 2009 | 6.27% | 2.10% | 0.78x | 3.85x | Rs-24.60 Million |
| 2010 | 15.85% | 5.46% | 0.90x | 3.22x | Rs43.36 Million |
| 2011 | 16.37% | 6.00% | 0.91x | 3.01x | Rs54.31 Million |
| 2012 | 17.95% | 6.11% | 1.02x | 2.88x | Rs77.90 Million |
| 2013 | 20.83% | 6.62% | 1.07x | 2.93x | Rs125.89 Million |
| 2014 | 30.09% | 9.47% | 1.20x | 2.66x | Rs301.37 Million |
| 2015 | 24.50% | 9.47% | 1.16x | 2.23x | Rs267.09 Million |
| 2016 | 23.93% | 10.35% | 1.16x | 1.99x | Rs291.28 Million |
| 2017 | 20.30% | 10.35% | 0.95x | 2.06x | Rs262.91 Million |
| 2018 | 21.36% | 10.71% | 0.95x | 2.10x | Rs350.98 Million |
| 2019 | 22.71% | 10.17% | 1.11x | 2.01x | Rs481.96 Million |
| 2020 | 40.12% | 21.68% | 1.27x | 1.46x | Rs1.62 Billion |
| 2021 | 37.27% | 23.77% | 1.08x | 1.45x | Rs2.16 Billion |
| 2022 | 22.72% | 14.58% | 1.12x | 1.39x | Rs1.26 Billion |
| 2023 | 19.56% | 13.59% | 1.06x | 1.36x | Rs1.12 Billion |
| 2024 | 11.75% | 10.33% | 0.91x | 1.25x | Rs221.59 Million |
| 2025 | 13.27% | 11.84% | 0.88x | 1.28x | Rs458.65 Million |
| 2026 | 11.74% | 11.72% | 0.81x | 1.24x | Rs266.63 Million |
Industry Comparison
This section compares Alkyl Amines Chemicals Limited's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $13,766,220,667
- Average return on equity (ROE) among peers: 5.82%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Alkyl Amines Chemicals Limited (ALKYLAMINE) | Rs15.33 Billion | 10.28% | 0.24x | $1.01 Billion |
| Aarti Industries Limited (AARTIIND) | $56.05 Billion | 5.90% | 0.98x | $1.91 Billion |
| Aarti Surfactants Limited (AARTISURF) | $2.18 Billion | 9.78% | 0.94x | $44.03 Million |
| ABM International Limited (ABMINTLLTD) | $127.92 Million | -37.56% | 1.23x | $4.33 Million |
| Advanced Enzyme Technologies Limited (ADVENZYMES) | $10.31 Billion | 14.16% | 0.12x | $392.05 Million |
| Aether Industries Limited (AETHER) | $20.63 Billion | 4.00% | 0.16x | $2.17 Billion |
| Akzo Nobel India Limited (AKZOINDIA) | $2.69 Billion | 18.78% | 1.53x | $1.60 Billion |
| Alkali Metals Limited (ALKALI) | $513.46 Million | 2.20% | 1.13x | $7.55 Million |
| Ami Organics Limited (AMIORG) | $576.82 Million | 32.06% | 1.70x | $1.18 Billion |
| Anupam Rasayan India Limited (ANURAS) | $30.82 Billion | 3.03% | 0.71x | $1.49 Billion |
About Alkyl Amines Chemicals Limited
Alkyl Amines Chemicals Limited manufactures and supplies amines, amine derivatives, and other specialty chemicals in India and internationally. The company offers aliphatic amines, such as methylamines, ethylamines, isopropylamines, n-propylamines, n-butylamines, ethylhexylamines, furfurylamines, and cyclohexylamines; and amine derivatives, including dimethylamine hydrochloride, diethylamine hydr… Read more